ONTY....folks have suggested they might get compassionate use ok based on Merck's subset analyses to be shared at ASCO. Regardless of what the STIMUVAX subsets show.....they are apparently well on the way to a better vaccine that elicits both immuno and cellular response......They have great scientists....I just think the long development time for Stimuvax hurt them, as science marches on, and they now have even a better one...with that said...believe ASCO will show very good effects in certain non late stage cancer.....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.